Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Dyne Therapeutics, Inc. | 10%+ Owner | Common Stock | 5.7M | $144M | $25.25 | Feb 28, 2024 | Direct |
Day One Biopharmaceuticals, Inc. | 10%+ Owner | Common Stock | 6.01M | $70.2M | $11.69 | Dec 12, 2022 | Direct |
Dyne Therapeutics, Inc. | 10%+ Owner | Common Stock | 864K | $21.8M | $25.25 | Feb 28, 2024 | Indirect |
Ikena Oncology, Inc. | 10%+ Owner | Common Stock | 1.24M | $6.67M | $5.37 | Dec 14, 2021 | Direct |
Third Harmonic Bio, Inc. | 10%+ Owner | Common Stock | 594K | $6.12M | $10.30 | Sep 19, 2022 | Direct |
Ikena Oncology, Inc. | 10%+ Owner | Common Stock | 875K | $4.7M | $5.37 | Mar 30, 2021 | Indirect |
Xilio Therapeutics, Inc. | 10%+ Owner | Common Stock | 2.02M | $1.29M | $0.64 | Feb 8, 2024 | Direct |
Xilio Therapeutics, Inc. | 10%+ Owner | Common Stock | 735K | $470K | $0.64 | Feb 8, 2024 | Indirect |
Third Harmonic Bio, Inc. | 10%+ Owner | Series A-1 Preferred Stock | 0 | Sep 19, 2022 | Direct | ||
Third Harmonic Bio, Inc. | 10%+ Owner | Series A-2 Preferred Stock | 0 | Sep 19, 2022 | Direct | ||
Third Harmonic Bio, Inc. | 10%+ Owner | Series A-3 Preferred Stock | 0 | Sep 19, 2022 | Direct | ||
Third Harmonic Bio, Inc. | 10%+ Owner | Series B Preferred Stock | 0 | Sep 19, 2022 | Direct |